ProShare Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-19,203
| Closed | -$99K | – | 1722 |
|
|
2019
Q2 | $99K | Sell |
19,203
-2,354
| -11% | -$10.6K | ﹤0.01% | 1533 |
|
|
2019
Q1 | $78K | Buy |
21,557
+168
| +0.8% | +$728 | ﹤0.01% | 1591 |
|
|
2018
Q4 | $131K | Sell |
21,389
-3,612
| -14% | -$22K | ﹤0.01% | 1438 |
|
|
2018
Q3 | $146K | Sell |
25,001
-567
| -2% | -$2.83K | ﹤0.01% | 1642 |
|
|
2018
Q2 | $109K | Buy |
25,568
+397
| +2% | +$2K | ﹤0.01% | 1701 |
|
|
2018
Q1 | $111K | Sell |
25,171
-4,139
| -14% | -$18.5K | ﹤0.01% | 1626 |
|
|
2017
Q4 | $154K | Buy |
29,310
+2,303
| +9% | +$14.1K | ﹤0.01% | 1684 |
|
|
2017
Q3 | $166K | Buy |
27,007
+1,685
| +7% | +$10.7K | ﹤0.01% | 1299 |
|
|
2017
Q2 | $183K | Buy |
25,322
+1,709
| +7% | +$10.5K | ﹤0.01% | 1359 |
|
|
2017
Q1 | $125K | Sell |
23,613
-6,217
| -21% | -$42K | ﹤0.01% | 1497 |
|
|
2016
Q4 | $214K | Buy |
29,830
+4,203
| +16% | +$34K | ﹤0.01% | 1561 |
|
|
2016
Q3 | $240K | Sell |
25,627
-4,765
| -16% | -$39.6K | ﹤0.01% | 1257 |
|
|
2016
Q2 | $192K | Buy |
30,392
+1,038
| +4% | +$6.68K | ﹤0.01% | 1432 |
|
|
2016
Q1 | $162K | Sell |
29,354
-3,114
| -10% | -$11.7K | ﹤0.01% | 1454 |
|
|
2015
Q4 | $181K | Buy |
32,468
+2,970
| +10% | +$19.6K | ﹤0.01% | 1565 |
|
|
2015
Q3 | $250K | Sell |
29,498
-2,136
| -7% | -$36.1K | ﹤0.01% | 1216 |
|
|
2015
Q2 | $478K | Sell |
31,634
-1,873
| -6% | -$27K | 0.01% | 1118 |
|
|
2015
Q1 | $536K | Buy |
33,507
+4,357
| +15% | +$77.5K | 0.01% | 1141 |
|
|
2014
Q4 | $519K | Buy |
+29,150
| New | +$363K | 0.01% | 1182 |
|
|
2014
Q3 | – | Sell |
-11,905
| Closed | -$186K | – | 2404 |
|
|
2014
Q2 | $186K | Buy |
+11,905
| New | +$169K | ﹤0.01% | 2204 |
|
Other funds holding PETX
ProShare Advisors's PETX Position: Q3 2019 in Review
ProShare Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 19,203 shares — an estimated $99K sold.
ProShare Advisors first reported a position in PETX in Q2 2014 and held it in 20 quarters. The position peaked at $536K in Q1 2015. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- ProShare Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- ProShare Advisors sold 19,203 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $99K.
- ProShare Advisors first reported a position in Aratana Therapeutics, Inc. in Q2 2014 and held it in 20 quarters.
- ProShare Advisors's Aratana Therapeutics, Inc. position peaked at $536K in Q1 2015.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on ProShare Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.